Evidence map›Paper›PMID 24699462›Full record

ArticleBMJ open2014

Relationship between target organ damage and blood pressure, retinal vessel calibre, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes in patients with hypertension: a case-control study protocol (LOD-Hipertension).

Manuel A Gomez-Marcos, Rogelio Gonzalez-Sarmiento, José I Recio-Rodríguez, Cristina Agudo-Conde, Luis Gamella-Pozuelo, Nuria Perretta-Tejedor, Carlos Martínez-Salgado, Luis García-Ortiz, Members of the LOD-Hipertensión Group

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02022618 (Target Organ Damage and Blood Pressure, Retinal Vessels, Oxidative Stress and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02022618 completednot on this map

Target Organ Damage and Blood Pressure, Retinal Vessels, Oxidative Stress and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects (LOD-Hypertension)

TypeobservationalSponsorFundacion para la Investigacion y Formacion en Ciencias de la SaludRan2013 to 2016Enrolled454ConditionsHypertension
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Manuel A Gomez-MarcosInstituto de Investigación Biomédica de Salamanca (IBSAL). Primary Care Research Unit, La Alamedilla Health Center, Castilla and León Health Service-SACYL, Salamanca, Spain.
Rogelio Gonzalez-Sarmiento
José I Recio-Rodríguez
Cristina Agudo-Conde
Luis Gamella-Pozuelo
Nuria Perretta-Tejedor
Carlos Martínez-Salgado
Luis García-Ortiz
Members of the LOD-Hipertensión Group
Instituto de Investigación Biomédica de Salamanca · ESUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTarget organ damage (TOD) is associated with increased cardiovascular risk. The study objectives were to analyse the relationship of TOD to blood pressure, size of retinal arteries and veins, oxidative stress and different polymorphisms in the VAV-2 and VAV-3 genes in participants with hypertension. METHODS AND ANALYSIS: A case-control study to analyse the relationship between clinical, biochemical and genetic parameters and presence of cardiac, vascular and renal TOD in 486 patients with hypertension. Participants with TOD will be considered as cases, and those without TOD will be enrolled as controls. This will be a collaborative study conducted by the groups of Primary Care, Cardiovascular and Metabolic and Degenerative Diseases of the Instituto de Investigación Biomédica of Salamanca (IBSAL). Assessment of cardiac, renal and vascular TOD. Measurement of peripheral and central blood pressure, size of eye fundus arteries and veins, and oxidative stress, and polymorphisms in the VAV-2 and VAV-3 genes. ETHICS AND DISSEMINATION: The study will be conducted after approval is obtained from the Ethics Committee of Hospital Clínico Universitario of Salamanca. All study participants will sign an informed consent to agree to participate in the study, and another consent to agree on the genetic study, in compliance with the Declaration of Helsinki and the WHO standards for observational studies. The results of this study will allow for an understanding of the relationship of the different TODs with blood pressure, retinal artery and vein diameters, oxidative stress and polymorphisms in VAV-2 and VAV-3 genes. TRIAL REGISTRATION NUMBER: Clinical Trials. gov Identifier: NCT02022618.

Indexed as

Blood PressureOxidative StressAdultAgedAged, 80 and overCardiovascular DiseasesCase-Control StudiesCross-Sectional StudiesFemaleHemodynamicsHumansHypertensionKidneyMaleMiddle AgedPolymorphism, GeneticProto-Oncogene Proteins c-vavVAV2 protein, humanVAV3 protein, humanBlood pressureOxidative stressPolymorphisms.Retinal arteries and veinsTarget organ damage

Identifiers

PMID24699462
PMCPMC3987709
OpenAlexW2064700625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.